Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
74.6 CHF | -0.27% | +2.78% | +45.38% |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.38% | 1.34B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.77% | 248B | |
-1.64% | 219B | |
+11.08% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia